Scientific data from clinical trials: Investigators' responsibilities and rights

Hiram C. Polk; Talmadge A. Bowden; Layton F. Rikkers; Charles M. Balch; Claude H. Organ; John A. Murie; Walter J. Pories; Markus W. Buechler; John P. Neoptolemos; Victor W. Fazio; Seymour I. Schwartz; John L. Cameron; Keith A. Kelly; Jay L. Grosfeld; David W. McFadden; Wiley W. Souba; Basil A. Pruitt; K. Wayne Johnston; Robert B. Rutherford; Maurice E. Arregui; Carol E.H. Scott-Conner; Andrew L. Warshaw; Michael G. Sarr; Alfred Cuschieri; Bruce V. MacFadyen; Ronald K. Tompkins

Scientific data from clinical trials: Investigators' responsibilities and rights

Hiram C. Polk, Talmadge A. Bowden, Layton F. Rikkers, Charles M. Balch, Claude H. Organ, John A. Murie, Walter J. Pories, Markus W. Buechler, John P. Neoptolemos, Victor W. Fazio, Seymour I. Schwartz, John L. Cameron, Keith A. Kelly, Jay L. Grosfeld, David W. McFadden, Wiley W. Souba, Basil A. Pruitt, K. Wayne Johnston, Robert B. Rutherford, Maurice E. ArreguiCarol E.H. Scott-Conner, Andrew L. Warshaw, Michael G. Sarr, Alfred Cuschieri, Bruce V. MacFadyen, Ronald K. Tompkins

Gastroenterologic and General Surgery

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Based on recent reports, there are increasing concerns about the control of the scientific data obtained from clinical trials sponsored by industry. Many of the problems encountered are the result of restrictions contained in the research contracts that participating investigators are asked to sign. A number of solutions have been suggested to ensure the integrity of clinical trials, including the establishment of appropriately constituted trial oversight committees, negotiating noninterference pledges from industry sponsors, and creating proactive support of investigators' rights by organized medicine.

Original language	English (US)
Pages (from-to)	639-640
Number of pages	2
Journal	Archives of Surgery
Volume	137
Issue number	6
State	Published - Jun 18 2002

ASJC Scopus subject areas

Surgery

Cite this

Polk, H. C., Bowden, T. A., Rikkers, L. F., Balch, C. M., Organ, C. H., Murie, J. A., Pories, W. J., Buechler, M. W., Neoptolemos, J. P., Fazio, V. W., Schwartz, S. I., Cameron, J. L., Kelly, K. A., Grosfeld, J. L., McFadden, D. W., Souba, W. W., Pruitt, B. A., Johnston, K. W., Rutherford, R. B., ... Tompkins, R. K. (2002). Scientific data from clinical trials: Investigators' responsibilities and rights. Archives of Surgery, 137(6), 639-640.

Polk, HC, Bowden, TA, Rikkers, LF, Balch, CM, Organ, CH, Murie, JA, Pories, WJ, Buechler, MW, Neoptolemos, JP, Fazio, VW, Schwartz, SI, Cameron, JL, Kelly, KA, Grosfeld, JL, McFadden, DW, Souba, WW, Pruitt, BA, Johnston, KW, Rutherford, RB, Arregui, ME, Scott-Conner, CEH, Warshaw, AL, Sarr, MG, Cuschieri, A, MacFadyen, BV & Tompkins, RK 2002, 'Scientific data from clinical trials: Investigators' responsibilities and rights', Archives of Surgery, vol. 137, no. 6, pp. 639-640.

@article{2574f3f76be64e31a8a0d0d8a8200cf9,

title = "Scientific data from clinical trials: Investigators' responsibilities and rights",

abstract = "Based on recent reports, there are increasing concerns about the control of the scientific data obtained from clinical trials sponsored by industry. Many of the problems encountered are the result of restrictions contained in the research contracts that participating investigators are asked to sign. A number of solutions have been suggested to ensure the integrity of clinical trials, including the establishment of appropriately constituted trial oversight committees, negotiating noninterference pledges from industry sponsors, and creating proactive support of investigators' rights by organized medicine.",

author = "Polk, {Hiram C.} and Bowden, {Talmadge A.} and Rikkers, {Layton F.} and Balch, {Charles M.} and Organ, {Claude H.} and Murie, {John A.} and Pories, {Walter J.} and Buechler, {Markus W.} and Neoptolemos, {John P.} and Fazio, {Victor W.} and Schwartz, {Seymour I.} and Cameron, {John L.} and Kelly, {Keith A.} and Grosfeld, {Jay L.} and McFadden, {David W.} and Souba, {Wiley W.} and Pruitt, {Basil A.} and Johnston, {K. Wayne} and Rutherford, {Robert B.} and Arregui, {Maurice E.} and Scott-Conner, {Carol E.H.} and Warshaw, {Andrew L.} and Sarr, {Michael G.} and Alfred Cuschieri and MacFadyen, {Bruce V.} and Tompkins, {Ronald K.}",

year = "2002",

month = jun,

day = "18",

language = "English (US)",

volume = "137",

pages = "639--640",

journal = "JAMA Surgery",

issn = "2168-6254",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Scientific data from clinical trials

T2 - Investigators' responsibilities and rights

AU - Polk, Hiram C.

AU - Bowden, Talmadge A.

AU - Rikkers, Layton F.

AU - Balch, Charles M.

AU - Organ, Claude H.

AU - Murie, John A.

AU - Pories, Walter J.

AU - Buechler, Markus W.

AU - Neoptolemos, John P.

AU - Fazio, Victor W.

AU - Schwartz, Seymour I.

AU - Cameron, John L.

AU - Kelly, Keith A.

AU - Grosfeld, Jay L.

AU - McFadden, David W.

AU - Souba, Wiley W.

AU - Pruitt, Basil A.

AU - Johnston, K. Wayne

AU - Rutherford, Robert B.

AU - Arregui, Maurice E.

AU - Scott-Conner, Carol E.H.

AU - Warshaw, Andrew L.

AU - Sarr, Michael G.

AU - Cuschieri, Alfred

AU - MacFadyen, Bruce V.

AU - Tompkins, Ronald K.

PY - 2002/6/18

Y1 - 2002/6/18

N2 - Based on recent reports, there are increasing concerns about the control of the scientific data obtained from clinical trials sponsored by industry. Many of the problems encountered are the result of restrictions contained in the research contracts that participating investigators are asked to sign. A number of solutions have been suggested to ensure the integrity of clinical trials, including the establishment of appropriately constituted trial oversight committees, negotiating noninterference pledges from industry sponsors, and creating proactive support of investigators' rights by organized medicine.

AB - Based on recent reports, there are increasing concerns about the control of the scientific data obtained from clinical trials sponsored by industry. Many of the problems encountered are the result of restrictions contained in the research contracts that participating investigators are asked to sign. A number of solutions have been suggested to ensure the integrity of clinical trials, including the establishment of appropriately constituted trial oversight committees, negotiating noninterference pledges from industry sponsors, and creating proactive support of investigators' rights by organized medicine.

UR - http://www.scopus.com/inward/record.url?scp=0036275838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036275838&partnerID=8YFLogxK

M3 - Article

C2 - 12049532

AN - SCOPUS:0036275838

SN - 2168-6254

VL - 137

SP - 639

EP - 640

JO - JAMA Surgery

JF - JAMA Surgery

IS - 6

ER -

Scientific data from clinical trials: Investigators' responsibilities and rights

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this